Treating Scleroderma by Targeting Pro-Fibrotic Macrophages: Highlighting Biomarkers of M2-like Macrophages-Levels in Systemic Sclerosis

Time: 12:00 pm
day: Day 1 - Stream B - Morning

Details:

  • Highlighting macrophage activation states and the role of M2-like macrophages in fibrosis
  • Exploring novel approaches to targeting this type of pathogenic cell

Speakers: